KCT0008735已完成Unknown
A clinical trial to evaluate the effect of Banhabaekchulcheonmatang and Hwangryeonhaedoktang on the pharmacokinetics of atorvastatin in healthy adults
Koera University Guro Hospital0 个研究点目标入组 14 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19(Year) 至 50(Year)（—）
- 性别
- All
入选标准
- •1) Adults aged 19 to 50 years of age (inclusive) at the time of screening
- •2) Subjects with BMI of 18 to 32 kg/m2 (inclusive)
- •3) Subjects who agree to use medically acceptable methods of contraception and not to donate sperm or oocyte
- •4) Subjects who voluntarily decided to participate in the study and provided written consent to comply with the protocol
排除标准
- •1) Subjects with current or history of clinically significant cardiovascular, respiratory, hepatic, renal, hematological, gastrointestinal, endocrine, immunological, dermatological, or neuropsychiatric disease
- •2) Subjects with current or history of clinically significant hypersensitivity reactions or hypersensitivity reactions to the components or constituents of the investigational product
- •3) Subjects with current or history of clinically significant myopathy, or a history or family history of inherited muscular disorders
- •4) Subjects with a history of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
- •5) Subjects whose eGFR calculated by the CKD-EPI formula is 80mL/min or less at screening
- •6) Subjects whose AST or ALT levels are more than 2 times the upper limit of normal range, or total bilirubin levels are more than 1.5 times the upper limit of normal range at screening
- •7) Subjects who have taken the following medication or medication known to have significant drug interactions with the investigational product within the 2 weeks prior to the first administration day
- •A.Strong CYP3A4 inhibitor or inducer
- •B. Inhibitors of OATP1B1 or P-gp
- •C. Herbal medicine, Korean traditional medicine, or supplements that contains the ingredients of Banhabaekchulcheonmatang or Hwangryeonhaedoktang
- •8) Subjects who donated whole blood within 60 days or blood components within 30 days, or received blood transfusion within 30 days prior to the first administration day
- •9) Subjects who participated and have been exposed to an investigational product in other clinical study within 180 days prior to the first administration day
- •10) Subjects who consistently consumed alcohol (alcohol > 21 units/week [1 unit = 10 mL of pure alcohol]) within 2 weeks of the first administration day
- •11) Pregnant or breastfeeding women
- •12) Subjects judged unsuitable to participate in the clinical study by investigators due to other reasons, including the results of laboratory tests
研究者
相似试验
已完成
Unknown
A clinical trial to evaluate the effect of Banhabaekchulcheonmatang and Hwangryeonhaedoktang on the pharmacokinetics and pharmacodynamics of edoxaban in healthy adultsKCT0008412Koera University Guro Hospital14
尚未招募
不适用
Sadyasnehapan with bahusneha ksheerpeya to observe samyak siddhi lakshanas(signs of internal oleation) within 3days of administratioCTRI/2022/11/047781PDEAs college of ayurveda and reseach centre Nigadi,pune
尚未招募
Unknown
A clinical trial to evaluate the effect of Bojungikgitang, Ijintang, or Cheongsanggyeontongtang on the pharmacokinetics of atorvastatin in healthy adultsKCT0009553Koera University Guro Hospital30
尚未招募
Unknown
A clinical trial to evaluate the effect of Bojungikgitang, Ijintang, or Cheongsanggyeontongtang on the pharmacokinetics and pharmacodynamics of edoxaban in healthy adultsKCT0009530Koera University Guro Hospital30
尚未招募
2 期
A clinical trial To study the effect of Bharangyadi Kwatha & Kaliphala Churna in the management of Shwasa roga w.s.r. To COPDCTRI/2023/11/059565Dr Anjana Mishra